Position in GILD
as of Mar 31, 2026
· filed Jun 10, 2026
Position Value
$256,440
+$126,348 QoQ
Shares Held
1,840
+57.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Sep 30, 2025CallValue
$111,000
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FAS Wealth Partners, Inc. holds $43,360,679 across 8 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,858 | $13,023,412 | |
| 2 | JNJ |
Johnson & Johnson
|
41,193 | $10,461,786 | |
| 3 | ABBV |
AbbVie Inc.
|
32,676 | $8,222,588 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,241 | $5,556,468 | |
| 5 | AMGN |
Amgen Inc
|
12,997 | $4,706,473 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,426 | $715,986 | |
| 7 | PFE |
Pfizer Inc
|
17,043 | $410,395 | |
| 8 | AZN |
Astrazeneca PLC
|
1,390 | $263,571 |
All Filings in GILD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $256,440 | 1,840 | Shares | Sole | 2026-06-10 | |
| 2025-09-30 | $130,092 | 1,172 | Shares | Sole | 2025-10-29 | |
| 2025-09-30 | $111,000 | 1,000 | Call | Sole | 2025-10-29 | |
| No filing history on record for this holder in this stock. | ||||||